Civilization Ventures — Activity | F4

Team Portfolio Raise Read Contact

F4/Civilization Ventures/Activity

Civilization Ventures Activity

Every public signal F4 has attached to this firm, with sources and cross-entity links.

Types

Time range

Investment

Participated in 10x Science's $4.8M seed round for AI-powered drug candidate characterization platform.

10x Science

10x ScienceCivilization Ventures

techcrunch.comAPR 22, 2026

hpcwire.com

APR 22, 2026

Exit

Portfolio company Catalog was acquired by Biomemory, combining DNA-based data storage technology with enzymatic bio-secure assembly.

Catalog Technologies

Catalog TechnologiesCivilization Ventures

datacenterdynamics.comMAR 11, 2026

MAR 11, 2026

Exit

Portfolio company Foresight Diagnostics acquired by Natera.

Foresight Diagnostics

Foresight Diagnostics Civilization Ventures

pitchbook.comDEC 5, 2025

businesswire.com

DEC 5, 2025

Investment

Participated in Trial Library's $10M Series A, co-led by SemperVirens and Next Ventures.

Trial Library

Trial Library Civilization Ventures

triallibrary.comDEC 2, 2025

accessnewswire.com

DEC 2, 2025

Exit

Portfolio company BillionToOne completed IPO on NASDAQ at a $5 billion valuation after upsized offering.

BillionToOne

BillionToOne Civilization Ventures

nasdaq.comNOV 2025

NOV 2025

Exit

Portfolio company Omada Health completed IPO on NASDAQ under ticker OMDA at $23 per share.

Omada Health

Omada Health Civilization Ventures

investors.omadahealth.comJUN 6, 2025

JUN 6, 2025

Essay

Published analysis of the delivery landscape in gene and cell therapy, introducing Nanite as a solution for AI-driven formulation discovery.

Solving the delivery problem

Civilization Ventures

civilizationventures.substack.comFEB 20, 2025

FEB 20, 2025

Investment

Announced investment in Nanite, an AI platform for designing safer, redosable therapeutics through polymer nanoparticle delivery.

Nanite

NaniteCivilization Ventures

civilizationventures.substack.comFEB 20, 2025

FEB 20, 2025

Investment

Participated in Series A funding round for Oxford Cancer Analytics' AI-driven blood tests for early cancer detection, raising $11M.

OXCan

OXCan Civilization Ventures

oxcan.orgJAN 9, 2025

JAN 9, 2025